SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 397 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 3,660,798 | $419,234,587 | 10.27% |
Casdin Capital, LLC | 1,015,000 | $116,237,800 | 10.16% |
Avoro Capital Advisors LLC | 4,627,888 | $529,985,734 | 7.19% |
Finepoint Capital LP | 125,457 | $14,367,336 | 4.97% |
Logos Global Management LP | 300,000 | $34,356,000 | 4.67% |
Saturn V Capital Management LLC | 53,995 | $6,183,507 | 3.43% |
Ghost Tree Capital, LLC | 85,000 | $9,734,200 | 3.21% |
Boxer Capital, LLC | 600,000 | $68,712 | 3.19% |
Artia Global Partners LP | 77,162 | $8,836,592 | 3.05% |
GREAT POINT PARTNERS LLC | 123,600 | $14,154,672 | 2.77% |
Evolutionary Tree Capital Management, LLC | 19,836 | $2,271,619 | 2.74% |
Altium Capital Management LP | 28,000 | $3,206,560 | 2.43% |
Ikarian Capital, LLC | 122,100 | $13,982,892 | 2.23% |
Eagle Health Investments LP | 97,340 | $11,147,377 | 2.08% |
Camber Capital Management LP | 400,000 | $45,808 | 1.49% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 348,595 | $39,921,099 | 1.48% |
SPHERA FUNDS MANAGEMENT LTD. | 78,300 | $8,966,916 | 1.40% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 327,700 | $37,528,204 | 1.39% |
Orbimed Advisors | 654,000 | $74,896,080 | 1.36% |
Avidity Partners Management LP | 297,500 | $34,069,700 | 1.19% |
External links
This page lists SAREPTA THERAPEUTICS INC's shareholders in Q2 2023. To view SAREPTA THERAPEUTICS INC's shareholder history, click here.